Agent-Specific Effects of Anticoagulant-Induced Alopecia

May 2017 in “ Research and Practice in Thrombosis and Haemostasis ”

Angela C. Weyand, Jordan A. Shavit

alopecia anticoagulants heparin derivatives new oral anticoagulants fondaparinux

Studysummary This case report observed that a 20-year-old female with recurrent DVTs experienced reversible alopecia with various anticoagulants, except fondaparinux which allowed long-term treatment without this side effect.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research Agent-Specific Effects of Anticoagulant-Induced Alopecia

7 citations , May 2017 in “Research and Practice in Thrombosis and Haemostasis”

This case report observed that a 20-year-old female with recurrent DVTs experienced reversible alopecia with various anticoagulants, except fondaparinux which allowed long-term treatment without this side effect.

research Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature

31 citations , January 2016 in “Drugs - Real World Outcomes”

This review discusses the potential link between direct oral anticoagulants and hair loss, suggesting DOACs may not be a suitable alternative for patients with alopecia from traditional anticoagulants; however, no clinical results are reported.

research Rivaroxaban-Induced Hair Loss

8 citations , August 2015 in “European Journal of Clinical Pharmacology”

This case report suggests that hair loss may be a potential adverse effect of rivaroxaban, though it is not listed in the product characteristics.

research Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden NOAC Registry (NCT01588119)

8 citations , November 2012 in “Blood”

This study observed that the incidence of hair loss as a spontaneously reported side effect of novel oral anticoagulant therapy is approximately 4.4 per 100 patient years.

research Alopecia in Women: A 2003 Review

18 citations , March 2003 in “PubMed”

This narrative review describes various types of alopecia in women and their diagnostic and treatment approaches but presents no new clinical findings.

research Drug-Associated Alopecia

63 citations , March 1995 in “International Journal of Dermatology”

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

research Hair Growth Inhibition by Heparin in Mice: A Model System for Studying the Modulation of Epithelial Cell Growth by Glycosaminoglycans

46 citations , May 1991 in “British Journal of Dermatology”

In this study, heparin was found to exert dose- and hair cycle-dependent effects on skin epithelial cells in mice, affecting hair follicle development and protein synthesis differently based on its administration method.

research Captopril and Alopecia: A Case Report and Review of Known Cutaneous Reactions in Captopril Use

20 citations , July 1990 in “Journal of the American Academy of Dermatology”

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

research Alopecia: A Pathologist's View

23 citations , July 1982 in “International Journal of Dermatology”

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.